Tesamorelin + Ipamorelin Blend 10mg / 3mg

 99

Tesamorelin / Ipamorelin 10 mg / 3 mg
Grail Formula high-purity dual research peptide blend.

Liquilabs verified. Validated assay content: 11.22 mg Tesamorelin and 3.39 mg Ipamorelin.
Endotoxins below 0.001 EU per mg. No detectable microbial growth or heavy metals.

For research use only — not for human or veterinary use.

Availability: In stock: ships within 1 day after payment confirmation.

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only — not for human or veterinary use.


Product Overview

Tesamorelin / Ipamorelin is a dual-component research peptide blend developed for laboratory investigation of growth-hormone–related signalling pathways, receptor interaction dynamics and endocrine feedback modelling. This lyophilized preparation combines two analytically verified peptides in a 10 mg and 3 mg configuration, supporting reproducible and well-controlled in vitro research applications.


Peptide Overview

Tesamorelin is a synthetic analogue of growth hormone–releasing hormone that has been studied in research settings since the early 2000s for its role in GHRH receptor activation and downstream endocrine signalling cascades. Ipamorelin, introduced in the same period, is a selective ghrelin-receptor agonist analogue researched for its receptor specificity and reduced interaction with non-target pathways.

When evaluated together, this peptide combination allows researchers to explore coordinated receptor signalling behaviour, endocrine pulse-modulation models and temporal response patterns within hormonally regulated biochemical systems.


Historical Background and Scientific Context

From the late 1990s through the 2000s, research into growth hormone–associated peptides expanded significantly as laboratories aimed to better understand endocrine regulation, pulsatile hormone signalling and metabolic feedback mechanisms. Dual-peptide research models such as Tesamorelin and Ipamorelin have since been referenced in preclinical literature as tools for studying combined receptor stimulation and signalling modulation under controlled experimental conditions.


Mechanistic Focus in Research

  • Growth hormone–related receptor signalling analysis
  • Endocrine feedback and pulse-modulation modelling
  • Receptor selectivity and pathway interaction research
  • Comparative structure–function investigation
  • Controlled in vitro endocrine signalling studies

Analytical Verification (COA)

Independent Liquilabs analysis confirms full validation for Batch GF092025063. Key analytical results include:

  • Tesamorelin Assay Content: 11.22 mg
  • Tesamorelin Identification – Retention Time: 0.998
  • Ipamorelin Assay Content: 3.39 mg
  • Ipamorelin Identification – Retention Time: 0.996
  • Endotoxins: below 0.001 EU per mg
  • Bioburden: not detected
  • Heavy Metals: not detected including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium

All analytical values were obtained using validated chromatographic, spectroscopic and microbiological procedures, ensuring transparent documentation and complete batch traceability.


Research Applications

  • Endocrine and growth hormone signalling research
  • Receptor interaction and pulse-modulation studies
  • Biochemical feedback-loop analysis
  • Comparative dual-peptide pathway evaluation
  • Controlled in vitro signalling investigations

Grail Formula Quality

Every Grail Formula research peptide blend undergoes independent third-party laboratory testing for identity, assay accuracy, purity and microbial safety. Each batch is verified for low endotoxin levels, analytical consistency and reproducibility to support reliable scientific research outcomes.


When You Choose Grail Formula…

Researchers receive fully documented peptide materials with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.


Used solely for in vitro experiments and cannot be:

  • Used in clinical trials involving humans
  • Administered to humans as part of an experiment or investigation
  • Supplied to another party for human investigational use

Verified and analysed with Liquilabs s.r.o. (Czechia)
High-purity dual research peptide blend
Validated assay content: 11.22 mg Tesamorelin and 3.39 mg Ipamorelin
Retention time identification and full COA traceability
Endotoxin levels below 0.001 EU per mg
No detectable heavy metals or microbial growth
EU shipments include bacteriostatic water
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.

Related Products